Pharma & Healthcare
Global Glucagon Market Research Report 2025
- Mar 11, 25
- ID: 30421
- Pages: 84
- Figures: 83
- Views: 11
The global market for Glucagon was valued at US$ 625 million in the year 2024 and is projected to reach a revised size of US$ 941 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucagon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon.
The Glucagon market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glucagon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucagon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Segment by Type
Inject Glucagon
Nasal Glucagon
Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucagon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucagon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon.
The Glucagon market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glucagon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glucagon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
Segment by Type
Inject Glucagon
Nasal Glucagon
Segment by Application
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucagon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Glucagon Market Overview
1.1 Product Definition
1.2 Glucagon by Type
1.2.1 Global Glucagon Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon by Application
1.3.1 Global Glucagon Market Value by Application (2024 VS 2031)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Market Size Estimates and Forecasts
1.4.1 Global Glucagon Revenue 2020-2031
1.4.2 Global Glucagon Sales 2020-2031
1.4.3 Global Glucagon Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Glucagon Market Competition by Manufacturers
2.1 Global Glucagon Sales Market Share by Manufacturers (2020-2025)
2.2 Global Glucagon Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Glucagon Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Glucagon, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucagon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucagon, Product Type & Application
2.7 Global Key Manufacturers of Glucagon, Date of Enter into This Industry
2.8 Global Glucagon Market Competitive Situation and Trends
2.8.1 Global Glucagon Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glucagon Players Market Share by Revenue
2.8.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glucagon Market Scenario by Region
3.1 Global Glucagon Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Glucagon Sales by Region: 2020-2031
3.2.1 Global Glucagon Sales by Region: 2020-2025
3.2.2 Global Glucagon Sales by Region: 2026-2031
3.3 Global Glucagon Revenue by Region: 2020-2031
3.3.1 Global Glucagon Revenue by Region: 2020-2025
3.3.2 Global Glucagon Revenue by Region: 2026-2031
3.4 North America Glucagon Market Facts & Figures by Country
3.4.1 North America Glucagon Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Glucagon Sales by Country (2020-2031)
3.4.3 North America Glucagon Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glucagon Market Facts & Figures by Country
3.5.1 Europe Glucagon Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Glucagon Sales by Country (2020-2031)
3.5.3 Europe Glucagon Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucagon Market Facts & Figures by Region
3.6.1 Asia Pacific Glucagon Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Glucagon Sales by Region (2020-2031)
3.6.3 Asia Pacific Glucagon Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Glucagon Market Facts & Figures by Country
3.7.1 Latin America Glucagon Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Glucagon Sales by Country (2020-2031)
3.7.3 Latin America Glucagon Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucagon Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucagon Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Glucagon Sales by Country (2020-2031)
3.8.3 Middle East and Africa Glucagon Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucagon Sales by Type (2020-2031)
4.1.1 Global Glucagon Sales by Type (2020-2025)
4.1.2 Global Glucagon Sales by Type (2026-2031)
4.1.3 Global Glucagon Sales Market Share by Type (2020-2031)
4.2 Global Glucagon Revenue by Type (2020-2031)
4.2.1 Global Glucagon Revenue by Type (2020-2025)
4.2.2 Global Glucagon Revenue by Type (2026-2031)
4.2.3 Global Glucagon Revenue Market Share by Type (2020-2031)
4.3 Global Glucagon Price by Type (2020-2031)
5 Segment by Application
5.1 Global Glucagon Sales by Application (2020-2031)
5.1.1 Global Glucagon Sales by Application (2020-2025)
5.1.2 Global Glucagon Sales by Application (2026-2031)
5.1.3 Global Glucagon Sales Market Share by Application (2020-2031)
5.2 Global Glucagon Revenue by Application (2020-2031)
5.2.1 Global Glucagon Revenue by Application (2020-2025)
5.2.2 Global Glucagon Revenue by Application (2026-2031)
5.2.3 Global Glucagon Revenue Market Share by Application (2020-2031)
5.3 Global Glucagon Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Glucagon Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly Glucagon Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Company Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi Glucagon Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Torrent Labs
6.4.1 Torrent Labs Company Information
6.4.2 Torrent Labs Description and Business Overview
6.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Torrent Labs Glucagon Product Portfolio
6.4.5 Torrent Labs Recent Developments/Updates
6.5 Taj Pharmaceuticals
6.5.1 Taj Pharmaceuticals Company Information
6.5.2 Taj Pharmaceuticals Description and Business Overview
6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
6.5.5 Taj Pharmaceuticals Recent Developments/Updates
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Company Information
6.6.2 Xeris Pharmaceuticals Description and Business Overview
6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
6.6.5 Xeris Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucagon Industry Chain Analysis
7.2 Glucagon Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucagon Production Mode & Process Analysis
7.4 Glucagon Sales and Marketing
7.4.1 Glucagon Sales Channels
7.4.2 Glucagon Distributors
7.5 Glucagon Customer Analysis
8 Glucagon Market Dynamics
8.1 Glucagon Industry Trends
8.2 Glucagon Market Drivers
8.3 Glucagon Market Challenges
8.4 Glucagon Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Glucagon by Type
1.2.1 Global Glucagon Market Value Comparison by Type (2024 VS 2031)
1.2.2 Inject Glucagon
1.2.3 Nasal Glucagon
1.3 Glucagon by Application
1.3.1 Global Glucagon Market Value by Application (2024 VS 2031)
1.3.2 Emergency Kits
1.3.3 General Use
1.3.4 Diagnostic & Motility
1.3.5 Cardiogenic Shock
1.3.6 Others
1.4 Global Glucagon Market Size Estimates and Forecasts
1.4.1 Global Glucagon Revenue 2020-2031
1.4.2 Global Glucagon Sales 2020-2031
1.4.3 Global Glucagon Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Glucagon Market Competition by Manufacturers
2.1 Global Glucagon Sales Market Share by Manufacturers (2020-2025)
2.2 Global Glucagon Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Glucagon Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Glucagon, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glucagon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucagon, Product Type & Application
2.7 Global Key Manufacturers of Glucagon, Date of Enter into This Industry
2.8 Global Glucagon Market Competitive Situation and Trends
2.8.1 Global Glucagon Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glucagon Players Market Share by Revenue
2.8.3 Global Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glucagon Market Scenario by Region
3.1 Global Glucagon Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Glucagon Sales by Region: 2020-2031
3.2.1 Global Glucagon Sales by Region: 2020-2025
3.2.2 Global Glucagon Sales by Region: 2026-2031
3.3 Global Glucagon Revenue by Region: 2020-2031
3.3.1 Global Glucagon Revenue by Region: 2020-2025
3.3.2 Global Glucagon Revenue by Region: 2026-2031
3.4 North America Glucagon Market Facts & Figures by Country
3.4.1 North America Glucagon Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Glucagon Sales by Country (2020-2031)
3.4.3 North America Glucagon Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glucagon Market Facts & Figures by Country
3.5.1 Europe Glucagon Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Glucagon Sales by Country (2020-2031)
3.5.3 Europe Glucagon Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucagon Market Facts & Figures by Region
3.6.1 Asia Pacific Glucagon Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Glucagon Sales by Region (2020-2031)
3.6.3 Asia Pacific Glucagon Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Glucagon Market Facts & Figures by Country
3.7.1 Latin America Glucagon Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Glucagon Sales by Country (2020-2031)
3.7.3 Latin America Glucagon Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucagon Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucagon Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Glucagon Sales by Country (2020-2031)
3.8.3 Middle East and Africa Glucagon Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glucagon Sales by Type (2020-2031)
4.1.1 Global Glucagon Sales by Type (2020-2025)
4.1.2 Global Glucagon Sales by Type (2026-2031)
4.1.3 Global Glucagon Sales Market Share by Type (2020-2031)
4.2 Global Glucagon Revenue by Type (2020-2031)
4.2.1 Global Glucagon Revenue by Type (2020-2025)
4.2.2 Global Glucagon Revenue by Type (2026-2031)
4.2.3 Global Glucagon Revenue Market Share by Type (2020-2031)
4.3 Global Glucagon Price by Type (2020-2031)
5 Segment by Application
5.1 Global Glucagon Sales by Application (2020-2031)
5.1.1 Global Glucagon Sales by Application (2020-2025)
5.1.2 Global Glucagon Sales by Application (2026-2031)
5.1.3 Global Glucagon Sales Market Share by Application (2020-2031)
5.2 Global Glucagon Revenue by Application (2020-2031)
5.2.1 Global Glucagon Revenue by Application (2020-2025)
5.2.2 Global Glucagon Revenue by Application (2026-2031)
5.2.3 Global Glucagon Revenue Market Share by Application (2020-2031)
5.3 Global Glucagon Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Glucagon Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly Glucagon Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Company Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fresenius Kabi Glucagon Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Torrent Labs
6.4.1 Torrent Labs Company Information
6.4.2 Torrent Labs Description and Business Overview
6.4.3 Torrent Labs Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Torrent Labs Glucagon Product Portfolio
6.4.5 Torrent Labs Recent Developments/Updates
6.5 Taj Pharmaceuticals
6.5.1 Taj Pharmaceuticals Company Information
6.5.2 Taj Pharmaceuticals Description and Business Overview
6.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
6.5.5 Taj Pharmaceuticals Recent Developments/Updates
6.6 Xeris Pharmaceuticals
6.6.1 Xeris Pharmaceuticals Company Information
6.6.2 Xeris Pharmaceuticals Description and Business Overview
6.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
6.6.5 Xeris Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucagon Industry Chain Analysis
7.2 Glucagon Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucagon Production Mode & Process Analysis
7.4 Glucagon Sales and Marketing
7.4.1 Glucagon Sales Channels
7.4.2 Glucagon Distributors
7.5 Glucagon Customer Analysis
8 Glucagon Market Dynamics
8.1 Glucagon Industry Trends
8.2 Glucagon Market Drivers
8.3 Glucagon Market Challenges
8.4 Glucagon Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Glucagon Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Glucagon Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Glucagon Market Competitive Situation by Manufacturers in 2024
Table 4. Global Glucagon Sales (K MT) of Key Manufacturers (2020-2025)
Table 5. Global Glucagon Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Glucagon Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Glucagon Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Glucagon Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Glucagon, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Glucagon, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glucagon, Product Type & Application
Table 12. Global Key Manufacturers of Glucagon, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glucagon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glucagon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Glucagon Sales by Region (2020-2025) & (K MT)
Table 18. Global Glucagon Sales Market Share by Region (2020-2025)
Table 19. Global Glucagon Sales by Region (2026-2031) & (K MT)
Table 20. Global Glucagon Sales Market Share by Region (2026-2031)
Table 21. Global Glucagon Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Glucagon Revenue Market Share by Region (2020-2025)
Table 23. Global Glucagon Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Glucagon Revenue Market Share by Region (2026-2031)
Table 25. North America Glucagon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Glucagon Sales by Country (2020-2025) & (K MT)
Table 27. North America Glucagon Sales by Country (2026-2031) & (K MT)
Table 28. North America Glucagon Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Glucagon Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Glucagon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Glucagon Sales by Country (2020-2025) & (K MT)
Table 32. Europe Glucagon Sales by Country (2026-2031) & (K MT)
Table 33. Europe Glucagon Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Glucagon Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Glucagon Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Glucagon Sales by Region (2020-2025) & (K MT)
Table 37. Asia Pacific Glucagon Sales by Region (2026-2031) & (K MT)
Table 38. Asia Pacific Glucagon Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Glucagon Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Glucagon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Glucagon Sales by Country (2020-2025) & (K MT)
Table 42. Latin America Glucagon Sales by Country (2026-2031) & (K MT)
Table 43. Latin America Glucagon Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Glucagon Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Glucagon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Glucagon Sales by Country (2020-2025) & (K MT)
Table 47. Middle East and Africa Glucagon Sales by Country (2026-2031) & (K MT)
Table 48. Middle East and Africa Glucagon Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Glucagon Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Glucagon Sales (K MT) by Type (2020-2025)
Table 51. Global Glucagon Sales (K MT) by Type (2026-2031)
Table 52. Global Glucagon Sales Market Share by Type (2020-2025)
Table 53. Global Glucagon Sales Market Share by Type (2026-2031)
Table 54. Global Glucagon Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Glucagon Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Glucagon Revenue Market Share by Type (2020-2025)
Table 57. Global Glucagon Revenue Market Share by Type (2026-2031)
Table 58. Global Glucagon Price (USD/MT) by Type (2020-2025)
Table 59. Global Glucagon Price (USD/MT) by Type (2026-2031)
Table 60. Global Glucagon Sales (K MT) by Application (2020-2025)
Table 61. Global Glucagon Sales (K MT) by Application (2026-2031)
Table 62. Global Glucagon Sales Market Share by Application (2020-2025)
Table 63. Global Glucagon Sales Market Share by Application (2026-2031)
Table 64. Global Glucagon Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Glucagon Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Glucagon Revenue Market Share by Application (2020-2025)
Table 67. Global Glucagon Revenue Market Share by Application (2026-2031)
Table 68. Global Glucagon Price (USD/MT) by Application (2020-2025)
Table 69. Global Glucagon Price (USD/MT) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Glucagon Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Eli Lilly Glucagon Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Fresenius Kabi Company Information
Table 81. Fresenius Kabi Description and Business Overview
Table 82. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Fresenius Kabi Glucagon Product
Table 84. Fresenius Kabi Recent Developments/Updates
Table 85. Torrent Labs Company Information
Table 86. Torrent Labs Description and Business Overview
Table 87. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Torrent Labs Glucagon Product
Table 89. Torrent Labs Recent Developments/Updates
Table 90. Taj Pharmaceuticals Company Information
Table 91. Taj Pharmaceuticals Description and Business Overview
Table 92. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Taj Pharmaceuticals Glucagon Product
Table 94. Taj Pharmaceuticals Recent Developments/Updates
Table 95. Xeris Pharmaceuticals Company Information
Table 96. Xeris Pharmaceuticals Description and Business Overview
Table 97. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Xeris Pharmaceuticals Glucagon Product
Table 99. Xeris Pharmaceuticals Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Glucagon Distributors List
Table 103. Glucagon Customers List
Table 104. Glucagon Market Trends
Table 105. Glucagon Market Drivers
Table 106. Glucagon Market Challenges
Table 107. Glucagon Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Glucagon
Figure 2. Global Glucagon Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Glucagon Market Share by Type: 2024 & 2031
Figure 4. Inject Glucagon Product Picture
Figure 5. Nasal Glucagon Product Picture
Figure 6. Global Glucagon Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Glucagon Market Share by Application: 2024 & 2031
Figure 8. Emergency Kits
Figure 9. General Use
Figure 10. Diagnostic & Motility
Figure 11. Cardiogenic Shock
Figure 12. Others
Figure 13. Global Glucagon Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Glucagon Market Size (2020-2031) & (US$ Million)
Figure 15. Global Glucagon Sales (2020-2031) & (K MT)
Figure 16. Global Glucagon Average Price (USD/MT) & (2020-2031)
Figure 17. Glucagon Report Years Considered
Figure 18. Glucagon Sales Share by Manufacturers in 2024
Figure 19. Global Glucagon Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Glucagon Players: Market Share by Revenue in Glucagon in 2024
Figure 21. Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Glucagon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Glucagon Sales Market Share by Country (2020-2031)
Figure 24. North America Glucagon Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Glucagon Sales Market Share by Country (2020-2031)
Figure 28. Europe Glucagon Revenue Market Share by Country (2020-2031)
Figure 29. Germany Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Glucagon Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Glucagon Revenue Market Share by Region (2020-2031)
Figure 36. China Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Glucagon Sales Market Share by Country (2020-2031)
Figure 46. Latin America Glucagon Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Glucagon Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Glucagon Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Glucagon by Type (2020-2031)
Figure 56. Global Revenue Market Share of Glucagon by Type (2020-2031)
Figure 57. Global Glucagon Price (USD/MT) by Type (2020-2031)
Figure 58. Global Sales Market Share of Glucagon by Application (2020-2031)
Figure 59. Global Revenue Market Share of Glucagon by Application (2020-2031)
Figure 60. Global Glucagon Price (USD/MT) by Application (2020-2031)
Figure 61. Glucagon Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Glucagon Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Glucagon Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Glucagon Market Competitive Situation by Manufacturers in 2024
Table 4. Global Glucagon Sales (K MT) of Key Manufacturers (2020-2025)
Table 5. Global Glucagon Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Glucagon Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Glucagon Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Glucagon Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Glucagon, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Glucagon, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glucagon, Product Type & Application
Table 12. Global Key Manufacturers of Glucagon, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glucagon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glucagon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Glucagon Sales by Region (2020-2025) & (K MT)
Table 18. Global Glucagon Sales Market Share by Region (2020-2025)
Table 19. Global Glucagon Sales by Region (2026-2031) & (K MT)
Table 20. Global Glucagon Sales Market Share by Region (2026-2031)
Table 21. Global Glucagon Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Glucagon Revenue Market Share by Region (2020-2025)
Table 23. Global Glucagon Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Glucagon Revenue Market Share by Region (2026-2031)
Table 25. North America Glucagon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Glucagon Sales by Country (2020-2025) & (K MT)
Table 27. North America Glucagon Sales by Country (2026-2031) & (K MT)
Table 28. North America Glucagon Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Glucagon Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Glucagon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Glucagon Sales by Country (2020-2025) & (K MT)
Table 32. Europe Glucagon Sales by Country (2026-2031) & (K MT)
Table 33. Europe Glucagon Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Glucagon Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Glucagon Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Glucagon Sales by Region (2020-2025) & (K MT)
Table 37. Asia Pacific Glucagon Sales by Region (2026-2031) & (K MT)
Table 38. Asia Pacific Glucagon Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Glucagon Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Glucagon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Glucagon Sales by Country (2020-2025) & (K MT)
Table 42. Latin America Glucagon Sales by Country (2026-2031) & (K MT)
Table 43. Latin America Glucagon Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Glucagon Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Glucagon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Glucagon Sales by Country (2020-2025) & (K MT)
Table 47. Middle East and Africa Glucagon Sales by Country (2026-2031) & (K MT)
Table 48. Middle East and Africa Glucagon Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Glucagon Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Glucagon Sales (K MT) by Type (2020-2025)
Table 51. Global Glucagon Sales (K MT) by Type (2026-2031)
Table 52. Global Glucagon Sales Market Share by Type (2020-2025)
Table 53. Global Glucagon Sales Market Share by Type (2026-2031)
Table 54. Global Glucagon Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Glucagon Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Glucagon Revenue Market Share by Type (2020-2025)
Table 57. Global Glucagon Revenue Market Share by Type (2026-2031)
Table 58. Global Glucagon Price (USD/MT) by Type (2020-2025)
Table 59. Global Glucagon Price (USD/MT) by Type (2026-2031)
Table 60. Global Glucagon Sales (K MT) by Application (2020-2025)
Table 61. Global Glucagon Sales (K MT) by Application (2026-2031)
Table 62. Global Glucagon Sales Market Share by Application (2020-2025)
Table 63. Global Glucagon Sales Market Share by Application (2026-2031)
Table 64. Global Glucagon Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Glucagon Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Glucagon Revenue Market Share by Application (2020-2025)
Table 67. Global Glucagon Revenue Market Share by Application (2026-2031)
Table 68. Global Glucagon Price (USD/MT) by Application (2020-2025)
Table 69. Global Glucagon Price (USD/MT) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Glucagon Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. Eli Lilly Glucagon Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Fresenius Kabi Company Information
Table 81. Fresenius Kabi Description and Business Overview
Table 82. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Fresenius Kabi Glucagon Product
Table 84. Fresenius Kabi Recent Developments/Updates
Table 85. Torrent Labs Company Information
Table 86. Torrent Labs Description and Business Overview
Table 87. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Torrent Labs Glucagon Product
Table 89. Torrent Labs Recent Developments/Updates
Table 90. Taj Pharmaceuticals Company Information
Table 91. Taj Pharmaceuticals Description and Business Overview
Table 92. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Taj Pharmaceuticals Glucagon Product
Table 94. Taj Pharmaceuticals Recent Developments/Updates
Table 95. Xeris Pharmaceuticals Company Information
Table 96. Xeris Pharmaceuticals Description and Business Overview
Table 97. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Xeris Pharmaceuticals Glucagon Product
Table 99. Xeris Pharmaceuticals Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Glucagon Distributors List
Table 103. Glucagon Customers List
Table 104. Glucagon Market Trends
Table 105. Glucagon Market Drivers
Table 106. Glucagon Market Challenges
Table 107. Glucagon Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Glucagon
Figure 2. Global Glucagon Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Glucagon Market Share by Type: 2024 & 2031
Figure 4. Inject Glucagon Product Picture
Figure 5. Nasal Glucagon Product Picture
Figure 6. Global Glucagon Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Glucagon Market Share by Application: 2024 & 2031
Figure 8. Emergency Kits
Figure 9. General Use
Figure 10. Diagnostic & Motility
Figure 11. Cardiogenic Shock
Figure 12. Others
Figure 13. Global Glucagon Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Glucagon Market Size (2020-2031) & (US$ Million)
Figure 15. Global Glucagon Sales (2020-2031) & (K MT)
Figure 16. Global Glucagon Average Price (USD/MT) & (2020-2031)
Figure 17. Glucagon Report Years Considered
Figure 18. Glucagon Sales Share by Manufacturers in 2024
Figure 19. Global Glucagon Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Glucagon Players: Market Share by Revenue in Glucagon in 2024
Figure 21. Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Glucagon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Glucagon Sales Market Share by Country (2020-2031)
Figure 24. North America Glucagon Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Glucagon Sales Market Share by Country (2020-2031)
Figure 28. Europe Glucagon Revenue Market Share by Country (2020-2031)
Figure 29. Germany Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Glucagon Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Glucagon Revenue Market Share by Region (2020-2031)
Figure 36. China Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Glucagon Sales Market Share by Country (2020-2031)
Figure 46. Latin America Glucagon Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Glucagon Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Glucagon Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Glucagon Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Glucagon by Type (2020-2031)
Figure 56. Global Revenue Market Share of Glucagon by Type (2020-2031)
Figure 57. Global Glucagon Price (USD/MT) by Type (2020-2031)
Figure 58. Global Sales Market Share of Glucagon by Application (2020-2031)
Figure 59. Global Revenue Market Share of Glucagon by Application (2020-2031)
Figure 60. Global Glucagon Price (USD/MT) by Application (2020-2031)
Figure 61. Glucagon Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232